Stocks
SYSMEX CORP UNSP/ASDRSSMY
HealthcareDiagnostics & Research
A global leader in in-vitro diagnostics, this Japanese firm develops and markets hematology, urinalysis, and flow cytometry systems, along with reagents and analyzers. Its position in clinical laboratory automation and cancer diagnostics makes it a key holding for healthcare investors tracking the diagnostics space.
Congressional Interest in SYSMEX CORP UNSP/ASDR (SSMY)
1 member of Congress has disclosed 1 trade in SYSMEX CORP UNSP/ASDR (SSMY), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading SSMY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-12-05 | Josh Gottheimer | sell | $1K-$15K |